© Synexa Life Sciences BV 2025
Blogs
- Resources
- Blogs
Latest Blogs
Establishing Biosimilarity: Regulatory and Scientific Expectations
A biosimilar is defined as a biologic product, highly similar to a reference or originator, with no clinically meaningful differences in terms of safety, purity,…
05 Jun, 2025 | Blogs
Video
Allogeneic CAR T cell therapies: A major step forward
In a groundbreaking clinical trial, three individuals suffering from severe autoimmune diseases have entered remission following a novel CAR T…
09 Oct, 2024 | Blogs
Video
A controlled detonation: Targeted antibody drug conjugates (ADCs) for oncology
Are antibody-drug conjugates (ADCs), principally comprised of an antibody, a cytotoxic payload and a linker, the next therapeutic modality of…
17 Sep, 2024 | Blogs
Video
The mpox outbreak: Variants, transmission and the boost for vaccine manufacturers
Following Covid-19, the world is collectively on high alert for anything that could indicate another pandemic. What do we know…
05 Sep, 2024 | Blogs
Video
The STING in the tail: How our own defense mechanisms to infection may be working against us
In this latest blog, we explore this pathway, its burgeoning links to multiple diseases and how biomarker profiling can assist…
29 Aug, 2024 | Blogs
Video
Falling drug approval rates: What should we be doing differently?
Over the years, this failure rate of drug approvals has not seen significant improvement, which begs the question - why?…
06 Aug, 2024 | Blogs
Video
Patient Derived Organoids: Shaping the Fight Against Paediatric Brain Cancer
We highlight some of the exciting translational tools that have been developed to understand brain cancer and how these are…
07 Jun, 2024 | Blogs
